Christopher Holt March 8, 2019
This week, the Trump Administration issued a
request for information (RFI) regarding the interstate sale of health
insurance. The publication is generating buzz because many conservatives have
long called for the sale of health insurance issued in one state to consumers
in other states. But just what is the sale of health insurance across
state lines, and what impact would it have?
In 1945, Congress passed the McCarran-Ferguson
Act, explicitly ceding insurance market regulations to state governments unless
enacted federal legislation explicitly declares its intent to preempt state
freedom in this matter. While the 1974 Employee Retirement Income Security Act
(ERISA) reasserted federal regulatory authority over self-insured employer
health insurance, the small-group and individual markets continued to be the
purview of the states. The Affordable Care Act (ACA) superseded state
individual and small group market regulation with its essential health benefits
package, but states were still free to enact their own laws and regulations
where such regulations exceeded the requirements of, or did not conflict with,
the ACA.
Today, states continue to have authority over
individual and small-group insurance. Some states have more restrictive rules around their insurance markets,
while others are more lax. This regulatory diversity is one—but only one—factor
that contributes to disparities in insurance premiums from one state to
another. Some argue that if consumers were free to purchase any
insurance product they wanted, regardless of where it was issued, we would see
increased competition and access to cheaper premiums. Consumers
effectively could circumvent their home states’ regulations and the price
pressures they bring.
Under current law, however, states are free to allow
out-of-state issuers to sell products in their state, if they so desire. There
are no existing federal prohibitions on the interstate sale of health
insurance. And, in fact, we have seen several examples of states
either opening their doors to out-of-state insurance products or entering into
agreements with neighboring states to allow sale of insurance products between
them. Most states, though, have been unwilling to open fully their
insurance markets. Further, where allowances have been made, no insurers
have taken advantage.
There are a couple of reasons why an insurer in
one state might not want to sell a product in another. For one, if they aren’t already active in both
states, they won’t have the network of providers in place to
deliver care. Further, labor costs are a significant factor in the cost of
insurance, so even if the insurer can establish a network of providers, the
cost of providing care won’t change simply because the insurer is located in
another state. On the other hand, if the insurer is already selling
insurance in both states, and its products are priced to account for those
geographical and regulatory cost variations, why would they undercut
their products in a more expensive market by selling products from another
cheaper state? There are also issues arising from disputes over
coverage. If a purchaser in one state takes issue with the insurance product
sold to them from another, which state’s regulatory apparatus
adjudicates?
Ultimately, there are no federal roadblocks to
the sale of insurance across state lines. There are, however, a number
of factors that make it unattractive to many states and to potential insurers. The
only way for the federal government to act that might bring
real competition and notable premium savings would be to preempt entirely
states’ ability to regulate their insurance markets and instead create, in
effect, a national insurance market. Such an approach, however, runs afoul of
the federalist inclinations of many of this policy’s advocates.
https://www.americanactionforum.org/weekly-checkup/selling-insurance-across-state-lines/#ixzz5hs5ulExbFollow @AAF on Twitter
No comments:
Post a Comment